Dr. Frisby-Zedan is a pediatric nephrologist at Lurie Children’s Hospital in Chicago. Her research focuses on pediatric AKI, critical care nephrology, and the long-term outcomes following hospital-acquired AKI. Her work has examined the risk factors that contribute to both short-term and long-term adverse outcomes in children with severe AKI requiring CRRT.
Currently, Dr. Frisby-Zedan serves as a site primary investigator for the Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Disease (WE-ROCK), a multicenter, multinational initiative dedicated to improving CRRT outcomes in children with AKI.
In addition, Dr. Frisby-Zedan is leading a collaborative research project with Dr. Rahul Chanchlani and Dr. Rajit Basu, funded by the Stanley Manne Children’s Research Institute at Lurie Children’s. The study, entitled “Optimization of Pediatric Hospital-Acquired Acute Kidney Injury Follow-up Utilizing a Risk Prediction Model for Development of Chronic Kidney Disease and a Community Engaged Approach,” has two primary goals:
- To derive and validate a risk prediction model for the development and timing of CKD among pediatric survivors of hospital-acquired AKI.
- To identify perceptions of and barriers to AKI follow-up among pediatric patients, referral providers, primary care providers, and pediatric nephrologists.
Recent example of Dr. Frisby-Zedan’s work:
Frisby-Zedan J, Barhight M, Chen W, Keswani M. Risk factors for adverse short-term and long-term outcomes in children with severe acute kidney injury requiring continuous kidney replacement therapy. Pediatric Nephrology. 2025 Aug;40(8):2679-2690. doi: 10.1007/s00467-025-06753-x. Epub 2025 Apr 11. PMID: 40214781.
ASPN Research Committee
